BRIEF published on 01/02/2025 at 09:00, 11 months 2 days ago Changes to the Board of Directors at Octopus Biosafety Board Of Directors Appointment Euronext Access International Development OCTOPUS BIOSAFETY
BRIEF published on 12/15/2024 at 08:05, 11 months 20 days ago Documents available for the Octopus Biosafety General Assembly Transparency General Assembly Euronext Access Financial Documents OCTOPUS BIOSAFETY
BRIEF published on 12/14/2024 at 18:15, 11 months 21 days ago Octopus Biosafety: Resumption of Stock Market Listing Stock Market Listing Euronext Access Paris OCTOPUS BIOSAFETY Commercial Court Observation Period
BRIEF published on 11/27/2024 at 17:50, 1 year ago Renewal of the observation period for Octopus Biosafety Funding Euronext Access OCTOPUS BIOSAFETY Commercial Court Judicial Recovery
BRIEF published on 07/21/2024 at 22:20, 1 year 4 months ago Postponement of the annual general meeting of Octopus Biosafety Audit General Assembly Report The Commercial Court OCTOPUS BIOSAFETY
BRIEF published on 05/31/2024 at 17:20, 1 year 6 months ago Placement of the company OCTOPUS BIOSAFETY into receivership Funding Legal Redress Euronext Access Paris OCTOPUS BIOSAFETY Lorient Commercial Court
Published on 12/05/2025 at 02:35, 3 hours 26 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 1 minute ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 56 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 1 minute ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 30 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 10 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 35 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 46 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 50 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 1 minute ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 16 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 16 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
